Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
OwnerDennis Browninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerDennis Browninventor
Estimating the term…
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutically active agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to therapeutically active agents selected from the group consisting of: (i) indirubin; (ii) an analog of indirubin; (iii) a derivative of indirubin or of an analog of indirubin; and (iv) a pharmaceutical composition comprising indirubin, an analog of indirubin, or a derivative of indirubin or of an analog of indirubin, especially meisoindigo.
A method to improve the efficacy and/or reduce the side effects of suboptimally administered drug therapy comprising the steps of:
(canceled)
-24. (canceled)
-29. (canceled)
-32. (canceled)
-35. (canceled)
-38. (canceled)
(canceled)
-54. (canceled)
-57. (canceled)
-60. (canceled)
-63. (canceled)
-66. (canceled)
-70. (canceled)
-74. (canceled)
-77. (canceled)
-80. (canceled)
82-87. (canceled)
-94. (canceled)
-106. (canceled)
-109. (canceled)
-115. (canceled)
-118. (canceled)
-124. (canceled)
-127. (canceled)
-131. (canceled)
(canceled)
(canceled)
(canceled)
-140. (canceled)
-144. (canceled)
-148. (canceled)
-151. (canceled)
-154. (canceled)
-157. (canceled)
A composition to improve the efficacy and/or reduce the side effects of suboptimally administered drug therapy comprising an alternative selected from the group consisting of:
(canceled)
-166. (canceled)
-171. (canceled)
(canceled)
-177. (canceled)
(canceled)
-183. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.